Edition:
United Kingdom

Hologic Inc (HOLX.OQ)

HOLX.OQ on NASDAQ Stock Exchange Global Select Market

38.87USD
20 Feb 2018
Change (% chg)

$-0.42 (-1.07%)
Prev Close
$39.29
Open
$39.24
Day's High
$39.30
Day's Low
$38.74
Volume
624,933
Avg. Vol
918,164
52-wk High
$46.80
52-wk Low
$35.34

Latest Key Developments (Source: Significant Developments)

Hologic Announces Pricing Of Offering Of $1 Bln Of Senior Notes
Wednesday, 17 Jan 2018 

Jan 16 (Reuters) - Hologic Inc ::HOLOGIC ANNOUNCES PRICING OF OFFERING OF $1 BILLION OF SENIOR NOTES.PRICED ‍$600 MILLION AGGREGATE PRINCIPAL AMOUNT OF ADDITIONAL 4.375% SENIOR NOTES DUE 2025 AT AN ISSUE PRICE OF $1,000 PER $1,000​.‍ PRICED $400 MILLION AGGREGATE PRINCIPAL AMOUNT OF 4.625% SENIOR NOTES DUE 2028 AT AN ISSUE PRICE OF $1,000 PER $1,000​.  Full Article

Hologic Announces Offering Of $1 Billion Of Senior Notes
Tuesday, 16 Jan 2018 

Jan 16 (Reuters) - Hologic Inc ::HOLOGIC ANNOUNCES OFFERING OF $1 BILLION OF SENIOR NOTES.HOLOGIC - LAUNCHED $1 BILLION OF SENIOR NOTES WHICH IS TO BE ALLOCATED BETWEEN ADDITIONAL 4.375% SENIOR NOTES DUE 2025 AND NEW SENIOR NOTES DUE 2028.HOLOGIC SAYS TO USE PROCEEDS OF OFFERING, AVAILABLE CASH TO REDEEM OUTSTANDING $1.0 BILLION 5.25% SENIOR NOTES DUE 2022.  Full Article

Third Respiratory Assay now FDA cleared on Hologic's new Panther Fusion system
Wednesday, 6 Dec 2017 

Dec 6 (Reuters) - Hologic Inc ::THIRD RESPIRATORY ASSAY NOW FDA CLEARED ON HOLOGIC'S NEW PANTHER FUSION® SYSTEM.HOLOGIC INC - ‍RECEIVED 510(K) CLEARANCE FROM FDA FOR PANTHER FUSION ADV/HMPV/RV ASSAY, A MULTIPLEXED ASSAY THAT RUNS ON NEW PANTHER FUSION SYSTEM​.  Full Article

HOLOGIC RECEIVES FDA 510(K) CLEARANCE OF QUANTRA 2.2 BREAST DENSITY ASSESSMENT SOFTWARE
Friday, 24 Nov 2017 

Nov 24 (Reuters) - Hologic Inc ::HOLOGIC RECEIVES FDA 510(K) CLEARANCE OF QUANTRA 2.2 BREAST DENSITY ASSESSMENT SOFTWARE.HOLOGIC INC- ‍HAS RECEIVED 510(K) CLEARANCE FROM U.S. FOOD AND DRUG ADMINISTRATION FOR QUANTRA 2.2 BREAST DENSITY ASSESSMENT SOFTWARE​.  Full Article

Hologic announces Q4 GAAP earnings per share $0.29
Wednesday, 8 Nov 2017 

Nov 8 (Reuters) - Hologic Inc ::Hologic announces financial results for fourth quarter of fiscal 2017.Q4 non-GAAP earnings per share $0.50.Q4 GAAP earnings per share $0.29.Q4 earnings per share view $0.49 -- Thomson Reuters I/B/E/S.Q4 revenue $802.9 million versus I/B/E/S view $792.5 million.Hologic Inc - ‍expect to post solid, mid-single-digit organic revenue growth in fiscal 2018​.  Full Article

Hologic - ‍received 510(k) clearance from FDA for Panther Fusion Paraflu assay​
Thursday, 26 Oct 2017 

Oct 26 (Reuters) - Hologic Inc :Hologic Inc - ‍received 510(k) clearance from FDA for Panther Fusion Paraflu assay​.  Full Article

FDA grants PMA approval for Hologic's Aptima hepatitis C Quant DX Assay
Wednesday, 15 Feb 2017 

Hologic Inc :FDA grants PMA approval for Hologic's Aptima hepatitis C Quant DX Assay.  Full Article

U.S. HHS awards $4.1 mln to Hologic to develop better Zika blood screening test
Tuesday, 9 Aug 2016 

U.S. Department of Health and Human Services: Awards $4.1 million to Hologic Inc to develop better Zika blood screening test . Under the one-year agreement, Hologic will advance the development of its Procleix Zika virus assay . Contract with Hologic could be extended up to 18 months and $6.2 million to support the clinical study Further company coverage: [HOLX.O] ((Bangalore.newsroom@thomsonreuters.com;)).  Full Article

Bovie Medical announces deal with Hologic Inc
Thursday, 21 Jul 2016 

Bovie Medical Corp : Bovie medical announces sales channel partnership agreement with hologic for J-Plasma® . Initial six-month agreement provides certain members of Hologic's direct gyn surgical sales force with access to J-Plasma(Reg) .Hologic will add Co's product line to healthcare solutions portfolio in gynecological gynecological/oncological surgery in 3 U.S. Regions.  Full Article

Hologic, Grifols say FDA approves Zika diagnostic test
Monday, 20 Jun 2016 

Hologic , Grifols : FDA has approved use of Procleix Zika virus blood screening assay on Procleix panther system under agency's investigational new drug study protocol .FDA approves use of the Procleix zika virus assay from Hologic and Grifols to screen the US blood supply under an IND study protocol.  Full Article

BRIEF-Hologic Reports Q1 GAAP Earnings Per Share $1.45

* HOLOGIC ANNOUNCES FINANCIAL RESULTS FOR FIRST QUARTER OF FISCAL 2018